| Register
| Log out
Submit An Article

Jo Patterson

Latest Articles

  • Bod commences cannabis trial with 500 Australians targeting anxiety and insomnia

    Bod commences cannabis trial with 500 Australians targeting anxiety and insomnia

    In a key advancement within Australia’s emerging medicinal cannabis market, Bod Australia (ASX: BDA) has commenced a national study which will be conducted over 12 months to trial the effectiveness of MediCabilis™ as a treatment for anxiety, insomnia and Post Traumatic Stress Disorder (PTSD). The study will be conducted Australia-wide with Bod having partnered with

    Read More
    Public
  • Bod receives first medicinal cannabis prescriptions in the UK

    Bod receives first medicinal cannabis prescriptions in the UK

    Cannabis healthcare company Bod Australia (ASX: BDA) has commenced its penetration of the lucrative UK medicinal cannabis market having received its first international prescriptions for their MediCabilis™ product.  With more than 7.3 million consumers of cannabis products in the UK annually, it represents a major addressable market for Bod which estimates its value to be

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.